Rare diseases
Investigational molecules
Locations
Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
AustriaStudy of inhaled BX004 bacteriophage treatment for adults with cystic fibrosis who have chronic Pseudomonas aeruginosa lung infection
CzechiaStudy of perineural incobotulinumtoxinA treatment for patients with Complex Regional Pain Syndrome type I or II affecting one side of the body
DenmarkStudy of zolbetuximab, pembrolizumab and chemotherapy in adults with HER2-negative, Claudin 18.
BelgiumStudy of Tibulizumab to Treat Adults with Hidradenitis Suppurativa
GermanyComparison of SRSD107 and enoxaparin to prevent blood clots in adults undergoing knee replacement surgery
BulgariaStudy comparing valemetostat tosylate plus pembrolizumab versus pembrolizumab alone in patients with advanced non-small cell lung cancer with high PD-L1 expression
FranceStudy of zorevunersen to reduce seizures in patients with Dravet syndrome
FranceStudy of rMenB+OMV NZ meningococcal group B vaccine immune response and safety in previously vaccinated healthy participants aged 10 to 20 years
FinlandStudy of cagrilintide for weight reduction in adults with overweight or obesity when combined with lifestyle changes
FranceLong-term safety and effectiveness study of verekitug injections in adults with severe asthma who completed the VALIANT trial
BulgariaStudy of FOLFIRI with domvanalimab and zimberelimab in patients with advanced gastric or gastro-esophageal junction cancer who progressed after chemotherapy
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
